drugset / Trial / NCT05552404

Postdural Puncture Headache Relief With Aminophylline and SPGB

NCT05552404

Phase 4 Completed 75 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to compare Sphenopalatine ganglion block (SPGB) and aminophylline in the efficacy and safety management of PDPH.

Timeline

Start
2022-10-01
Primary completion
2022-12-30
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aminophylline Small molecule 250 mg Intravenous

Indications

No indication recorded.